APA (7th ed.) Citation

MJ, M., B, D., IWT, Y., J, P., U, M., R, J., . . . KA, V. (2026). Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to 177Lu-DOTATATE in Neuroendocrine Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(5), 751. https://doi.org/10.2967/jnumed.125.271039

Chicago Style (17th ed.) Citation

MJ, Macsuka, et al. "Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to 177Lu-DOTATATE in Neuroendocrine Tumors." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 5 (2026): 751. https://doi.org/10.2967/jnumed.125.271039.

MLA (9th ed.) Citation

MJ, Macsuka, et al. "Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to 177Lu-DOTATATE in Neuroendocrine Tumors." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 5, 2026, p. 751, https://doi.org/10.2967/jnumed.125.271039.